Jennifer Fulk - 02 Mar 2026 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 17:59:56 UTC
Previous filing
08 Mar 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fulk Jennifer CHIEF FINANCIAL OFFICER 100 MARINE PARKWAY, SUITE 400, REDWOOD CITY /s/ Anish Bhatnagar, Attorney-in-Fact 04 Mar 2026 0001873522

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award +39,200 $0.000000* 39,200 02 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Options Exercise +67,660 $0.000000* 67,660 02 Mar 2026 Common Stock 67,660 $39.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 25% of RSUs shall vest on each of March 2, 2027, March 2, 2028, March 2, 2029 and March 2, 2030, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
F2 One-fourth of the shares subject to the option shall vest on March 2, 2027 and one forty-eighth of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.